Bipolar androgen therapy as platform for personalized medicine in castration-resistant prostate cancer

Puntos clave

• Bipolar androgen therapy significantly enhances treatment efficacy in castration-resistant prostate cancer, leading to improved patient outcomes.
• Clinical findings show a notable increase in survival rates with personalized treatment approaches based on individual responses to therapy.
• Analysis of hormone therapy interventions highlights the potential of tailoring therapies to individual patient profiles for better results.
• This approach suggests that personalized medicine could be a game-changer in treating advanced prostate cancer patients with limited options.